A new study describes the potential for two common plant products to make a difference in the management of severe COVID-19.
LONDON (Reuters) - Existing vaccines may protect against the Brazilian variant of the coronavirus, according to a University of Oxford study which examined the...
Our knowledge of Alzheimer's disease has grown rapidly in the past few decades but it has proven difficult to translate fundamental discoveries about the disease...
UNAIDS warmly welcomes the passing of the US$ 1.9 trillion American Rescue Plan Act. The historic legislation will deliver much-needed relief in the light of COVID-19,...
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential...
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, today announced a commercial partnership with Mologic.
The chemicals to blame for our reproductive crisis are found everywhere and in everything
Researchers at Imperial College London have discovered what causes normal proteins to convert to a diseased form causing conditions like CJD and Kuru The stud
People deemed clinically extremely vulnerable will no longer have to shield from Covid-19 from April 1 in England and Wales.
Researchers at Imperial College London have discovered what causes normal proteins to convert to a diseased form, causing conditions like CJD and Kuru. The study...